JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Signaling Pathways

Signaling Pathways

A8441 GSK461364

3 Citation

Target: PLK

Summary: Plk1 inhibitor
A8446 Ibuprofen

Target: COX

Summary: inhibitor of cyclooxygenase 1 and cyclooxygenase 2

insoluble in H2O; ≥10.31 mg/mL
A8447 Imidapril HCl

Target: ACE

Summary: RAAS inhibitor

insoluble in H2O; ≥16.5 mg/mL
A8448 INCB28060

Target: c-MET

Summary: C-Met inhibitor,ATP-competitive and novel

insoluble in EtOH; insoluble in H2O; ≥5.15 mg/mL
A8449 Indomethacin

Target: COX

Summary: Cox inhibitor
A8454 Istradefylline (KW-6002)

Target: Adenosine A2A Receptors

Summary: Selective A2A receptor antagonist

insoluble in H2O; insoluble in EtOH; ≥8.78 mg/mL
A8456 JTC-801

Target: NOP Receptors

Summary: KOR-3 (NOP) receptor antagonist

≥22.4 mg/mL
A8458 Lamivudine

Target: HBV Proteases

Summary: Nucleoside analog reverse transcriptase inhibitor

≥10.5 mg/mL
A8463 Lithocholic Acid

Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)

Summary: Activator of vitamin D receptor,PXR and FXR

insoluble in H2O; ≥12.95 mg/mL
A8464 LY2109761

4 Citation

Summary: TβRI/II kinase inhibitor

≥22.1 mg/mL